Sign in

CIK 0001781983

  • Non-accelerated filer
  • Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-06-30 Seizinger Bernd R. Director Grant or award · Stock Option (Right to Buy) +22,750 22,750
2021-06-30 Namouni Fouad Director Grant or award +4,610 4,610
2021-06-30 Namouni Fouad Director Grant or award · Stock Option (Right to Buy) +22,750 22,750
2021-03-10 Korbel Gregory Alan Chief Business Officer Grant or award +15,000 25,500
2021-02-25 Attar Eyal C. SVP, Chief Medical Officer Grant or award +33,000 33,000
2021-02-25 Attar Eyal C. SVP, Chief Medical Officer Grant or award +75,000 108,000
2021-02-25 Attar Eyal C. SVP, Chief Medical Officer Grant or award · Stock Option (right to Buy) +143,000 143,000
2021-02-25 Wessels Gregory S. SVP, Chief Commercial Officer Grant or award +16,000 16,000
2021-02-25 Wessels Gregory S. SVP, Chief Commercial Officer Grant or award · Stock Option (right to Buy) +66,000 66,000
2021-02-25 Abrahmsen Lars B. SVP, Chief Scientific Officer Grant or award +19,000 19,000
2021-02-25 Abrahmsen Lars B. SVP, Chief Scientific Officer Grant or award · Stock Option (right to Buy) +82,000 82,000
2021-02-25 SCHADE CHRISTIAN S Chairman & CEO Grant or award +77,000 77,160
2021-02-25 SCHADE CHRISTIAN S Chairman & CEO Grant or award +88,500 176,660
2021-02-25 SCHADE CHRISTIAN S Chairman & CEO Grant or award · Stock Option (right to Buy) +329,000 329,000
2021-02-25 Coiante Scott M SVP, Chief Financial Officer Grant or award +33,000 35,500
2021-02-25 Coiante Scott M SVP, Chief Financial Officer Grant or award +63,500 99,000
2021-02-25 Coiante Scott M SVP, Chief Financial Officer Grant or award · Stock Option (right to Buy) +143,000 143,000
2021-02-25 Korbel Gregory Alan VP of Business Dev't Grant or award +10,000 10,500
2021-02-25 Korbel Gregory Alan VP of Business Dev't Grant or award · Stock Option (right to Buy) +41,100 41,100
2020-12-28 Redmile Group, LLC 10% owner Sale −494,137 $5.58 $2.8M 1,774,581

Page 11 of 17 · 334 trades